newsfilter
← Latest News
GlobeNewswire·

VectivBio to Report Full Year 2022 Financial Results and Provide Business Update on Wednesday, April 19, 2023

BASEL, Switzerland, April 12, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG ("VectivBio") (NASDAQ:VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare